Opaleye Management Inc. - Insider Trading & Ownership

Entity
Company
Location
One Boston Place, Suite 2600, Boston, MA
Summary
The estimated value of insider holdings of Opaleye Management Inc. is at least $125M dollars as of November 1, 2024. Opaleye Management Inc. is the 10%+ Owner of HARROW, INC. and owns shares of HARROW, INC. (HROW) stock worth about $38M. Opaleye Management Inc. is the 10%+ Owner of CODEXIS, INC. and owns shares of CODEXIS, INC. (CDXS) stock worth about $24.9M. Opaleye Management Inc. is the 10%+ Owner of SANUWAVE Health, Inc. and owns shares of SANUWAVE Health, Inc. (SNWV) stock worth about $24.4M. Opaleye Management Inc. is the 10%+ Owner of Eton Pharmaceuticals, Inc. and owns shares of Eton Pharmaceuticals, Inc. (ETON) stock worth about $22.1M. Opaleye Management Inc. is the Former 10% Owner. of TELA Bio, Inc. and owns shares of TELA Bio, Inc. (TELA) stock worth about $11.7M. Opaleye Management Inc. is the 10%+ Owner of Protara Therapeutics, Inc. and owns shares of Protara Therapeutics, Inc. (TARA) stock worth about $3.4M.
All Insider Reports
All Insider Reports

Ownership of Opaleye Management Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HROW, HROWL HARROW, INC. 10%+ Owner $38M +$1.84M +5.09% Apr 25, 2024
CDXS CODEXIS, INC. 10%+ Owner $24.9M +$3.82M +18.2% Oct 25, 2024
SNWV, SNWVD SANUWAVE Health, Inc. 10%+ Owner $24.4M Oct 30, 2024
ETON Eton Pharmaceuticals, Inc. 10%+ Owner $22.1M +$585K +2.72% Oct 23, 2024
TELA TELA Bio, Inc. Former 10% Owner. $11.7M Apr 20, 2023
TARA Protara Therapeutics, Inc. 10%+ Owner $3.4M -$1.75M -34% Sep 11, 2024
TCON Tracon Pharmaceuticals, Inc. 10%+ Owner Nov 10, 2023

Insider Transactions Reported by Opaleye Management Inc.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.